hVIVO Revenue
Biotechnology Research • 
London, England, United Kingdom • 201-500 Employees
hVIVO revenue & valuation
| Annual revenue | $71,400,000 |
| Revenue per employee | $320,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $228,400,000 |
| Total funding | $2,600,000 |
Key Contacts at hVIVO
Melanie Smyth
Senior Director Of Clinical Operations
Rich Niemi
Senior Director Business Development
Nicolas Noulin
Director Clinical Science
Maria Menikou
Director Of Business Development
Alexander Mann
Senior Director, Clinical Sciences
Melissa Bevan
Associate Medical Director
Alison Boyers
Director, Laboratory Project Operations
Brandon Londt
Clinical Science Director
Richard Keeling
Director Data Management
Alexandra Devoti
Senior Director, Project Feasibility
Company overview
| Headquarters | 40 Bank Street, London, England E14 5NR, GB |
| Phone number | +442326557 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Diabetes, Clinical Research, CMC, Medical Research, Medical Devices, Endocrinology, Cardiology, Dermatology, Hematology, Clinical Trials, PD, Proof Of Concept, Metabolic Disorders, PK, Regulatory Writing, Malaria, Hepatology, Influenza, Phase 1, HRV, Lab Services, Copd, RSV, Asthma Studies, Challenge Models, Human Challenge Models, Human Models Of Disease, Human Volunteer Research, Respiratory Disease Research, Uk Clinical Trials, Covid 19, Respiratory Syncytial Virus, Challenge Studies, First In Human, Cardiometabolic, Human Rhinoviruse, Human Challenge Trials, Renal Impariment |
| Founded | 1989 |
| Employees | 201-500 |
| Socials |
hVIVO Email Formats
hVIVO uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@hvivo.com), used 95.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@hvivo.com | 95.9% |
{first initial}.{last name} | j.doe@hvivo.com | 4.1% |
About hVIVO
hVIVO plc (Ticker: HVO) is full-service Contract Research Organisation (CRO) and the global leader in human challenge trials. The company delivers end-to-end clinical development services to a diverse and expanding client base, including seven of the world's ten largest biopharma companies. hVIVO specialises in conducting human challenge trials across multiple infectious and respiratory indications, leveraging its state-of-the-art quarantine facility in London-the largest of its kind worldwide. The company also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its German subsidiary, CRS, hVIVO operates a 120-bed capacity across Mannheim and Kiel, providing early-phase clinical trial services, including first-in-human and proof-of-concept studies. Its second subsidiary, Venn Life Sciences, offers Early Drug Development Consulting and Biometry services to the biopharma sector. The Group provides fully integrated drug development solutions from preclinical stages through Phase II trials, alongside patient recruitment via FluCamp. Additionally, its five clinical sites support outpatient Phase II and III trials, ensuring a seamless and efficient pathway from discovery to late-stage development.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
hVIVO has 83 employees across 10 departments.
Departments
Number of employees
hVIVO Tech Stack
Discover the technologies and tools that power hVIVO's digital infrastructure, from frameworks to analytics platforms.
UI frameworks
Page builders
WordPress plugins
CDN
Marketing automation
JavaScript libraries
Webmail
Miscellaneous
Security
Programming languages
Blogs
Authentication
Croatia
Frequently asked questions
4.8
40,000 users
